Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07039435 · ClinicalTrials.gov registry record · NA

Perceptual Adaptation Following Cochlear Implantation (Aim 3a)

A NA study of Sensorineural Hearing Loss and Cochlear Implantation, sponsored by NYU Langone Health.

Recruiting
Registry status
NA
Development phase
22
Enrollment target
1
Study location

NCT07039435 is a NA study of Sensorineural Hearing Loss and Cochlear Implantation that is actively recruiting participants, run by NYU Langone Health. The registered enrollment target is 22 participants, below the 129-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07039435, a NA study of Sensorineural Hearing Loss and Cochlear Implantation, is actively recruiting participants, sponsored by NYU Langone Health.

RECRUITING
Registry status
NA
Development phase
22 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to study the adaptation process in newly implanted Single-Sided Deaf Cochlear Implant (SSD-CI) users. Subjects will use four frequency maps for the first month after CI activation. One of these maps will be standard of care and the other three will have higher low frequency edges than the standard of care default maps. These maps will alternate daily during the first month (with exceptions made for situations when the subject is allowed to use a preferred map rather than the map predetermined for use that day), and after that point each subject will make a selection at the beginning of the week to compare all four maps and decide which one to use at the beginning of the following week. The goal of this study is to investigate how reducing place-pitch mismatch in SSD CI users affects 1) sound quality, 2) device use, and 3) speech perception.

Interventions

  • OTHER Alternative Frequency Mapping

Study Locations (1)

New York

  • NYU Langone Health - New York

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2024-01-04
Est. Completion 2029-07-31
Phase NA

Sponsor

NYU Langone Health

1,164 total trials

What the Registry Record Tells You About NCT07039435

The ClinicalTrials.gov registry entry for NCT07039435 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 129-participant average among 13 other Sensorineural Hearing Loss trials with a reported enrollment target (83% lower). The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Sensorineural Hearing Loss appearing as the primary indexed condition, and to 1 intervention - of which Alternative Frequency Mapping is the first listed.

NCT07039435 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT07039435 about?

NCT07039435 is a clinical study titled "Perceptual Adaptation Following Cochlear Implantation (Aim 3a)". The goal of this study is to study the adaptation process in newly implanted Single-Sided Deaf Cochlear Implant (SSD-CI) users. Subjects will use four frequency maps for the first month after CI activation. One of these maps will be standard of care and the other three will have higher low frequency...

What is the current status of trial NCT07039435?

This trial is currently recruiting. It is a NA study. The enrollment target is 22 participants. The study started on 2024-01-04. Estimated completion is 2029-07-31.

What conditions does trial NCT07039435 study?

This clinical trial studies the following conditions: Sensorineural Hearing Loss, Cochlear Implantation, Perceptual Adaptation.

What interventions are being tested in trial NCT07039435?

The interventions under investigation include: Alternative Frequency Mapping (OTHER).

Who is sponsoring clinical trial NCT07039435?

This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07039435 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Sensorineural Hearing Loss

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.